BOSTON — Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program and Dana-Farber Cancer Institute’s adult stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.